In patients ≥ 65 years old, the rule-out power of PSA for advanced PCa, even in absence of glandular inflammation, is significantly reduced and the estimate of free PSA percentage may help to increase the NPV in patients with PSA concentrations ≤ 3.7 μg/L [19]. This evidence concerns the gene KLK3 and posterior cortical atrophy.